Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	320.72	36.39	8.65
Graham Fair Price	-64.85	2.67	7.60
PEG	8826.55	0.86	< 0.005
Price/Book	21.52	1.43	1.17
Price/Cash Flow	444.70	-21.36	3.92
Prices/Earnings	915.83	-96.88	9.54
Price/Sales	68.87	1.54	0.91
Price/FCF	444.70	-21.36	3.92
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-2.94	0.38	0.39
Operating Margin	-99.65	< 0.005	0.05
ROA	-87.17	< 0.005	< 0.005
ROE	0.03	< 0.005	-88.04
ROIC	0.02	< 0.005	-99.64
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.01	0.08	-83.71
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	38.29	-1.00	-97.39
EPS QOQ	9.86	-1.12	-88.62
FCF QOQ	5.69	-1.23	-78.42
Revenue QOQ	0.34	-0.27	-22.37
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	71.08	102.96	44.85
Days Sales Outstanding (DSO)	30.44	30.58	0.47
Inventory Turnover	1.27	0.87	-30.96
Debt/Capitalization	0.31	0.31	-0.51
Quick Ratio	1.03	0.96	-6.16
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	9.14	9.28	1.63
Cash	9.94	9.54	-4.08
Capex	-0.45	-0.23	48.80
Free Cash Flow	2.73	-0.62	-77.33
Revenue	11.77	8.60	-26.86
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.49	1.53	2.70
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-2.80	-5.12	-82.65
Naive Interpretation	Member

06 - Financial Health · Weak

Rating